http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101982001-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101982001-B1 |
| titleOfInvention | Method for selecting of anti-pd-1 or anti-pd-l1 antibodies using alloimmunity or xenoimmunity |
| abstract | The present invention relates to an anti-PD-1 or anti-PD-L1 antibody screening method using allogeneic or heterologous rejection. Antibodies can be selected at low cost by an antibody screening method according to the present invention, which is a model that simulates PD-1 and PD-L1 interactions between T cells and cancer cells. |
| priorityDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.